Logo image of CXW

CORECIVIC INC (CXW) Stock Fundamental Analysis

USA - NYSE:CXW - US21871N1019 - Common Stock

17.99 USD
-0.32 (-1.75%)
Last: 10/10/2025, 9:19:37 PM
17.509 USD
-0.48 (-2.67%)
After Hours: 10/10/2025, 9:19:37 PM
Fundamental Rating

5

CXW gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. CXW has an average financial health and profitability rating. CXW may be a bit undervalued, certainly considering the very reasonable score on growth This makes CXW very considerable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CXW was profitable.
In the past year CXW had a positive cash flow from operations.
CXW had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CXW had a positive operating cash flow.
CXW Yearly Net Income VS EBIT VS OCF VS FCFCXW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

CXW has a better Return On Assets (3.39%) than 66.67% of its industry peers.
CXW has a Return On Equity of 7.04%. This is in the better half of the industry: CXW outperforms 63.10% of its industry peers.
The Return On Invested Capital of CXW (5.45%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CXW is significantly below the industry average of 10.17%.
The last Return On Invested Capital (5.45%) for CXW is above the 3 year average (4.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROIC 5.45%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
CXW Yearly ROA, ROE, ROICCXW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

CXW's Profit Margin of 5.21% is fine compared to the rest of the industry. CXW outperforms 67.86% of its industry peers.
CXW's Profit Margin has declined in the last couple of years.
The Operating Margin of CXW (10.39%) is better than 72.62% of its industry peers.
In the last couple of years the Operating Margin of CXW has declined.
The Gross Margin of CXW (24.70%) is worse than 61.90% of its industry peers.
In the last couple of years the Gross Margin of CXW has declined.
Industry RankSector Rank
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
CXW Yearly Profit, Operating, Gross MarginsCXW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXW is destroying value.
Compared to 1 year ago, CXW has less shares outstanding
The number of shares outstanding for CXW has been reduced compared to 5 years ago.
The debt/assets ratio for CXW has been reduced compared to a year ago.
CXW Yearly Shares OutstandingCXW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CXW Yearly Total Debt VS Total AssetsCXW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that CXW is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CXW (1.59) is worse than 60.71% of its industry peers.
CXW has a debt to FCF ratio of 5.98. This is a neutral value as CXW would need 5.98 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.98, CXW is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CXW has a Debt/Equity ratio of 0.68. This is a neutral value indicating CXW is somewhat dependend on debt financing.
CXW's Debt to Equity ratio of 0.68 is in line compared to the rest of the industry. CXW outperforms 45.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Altman-Z 1.59
ROIC/WACC0.67
WACC8.17%
CXW Yearly LT Debt VS Equity VS FCFCXW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.60 indicates that CXW should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.60, CXW is in line with its industry, outperforming 57.14% of the companies in the same industry.
CXW has a Quick Ratio of 1.60. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
CXW has a better Quick ratio (1.60) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
CXW Yearly Current Assets VS Current LiabilitesCXW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.33% over the past year.
The earnings per share for CXW have been decreasing by -17.17% on average. This is quite bad
The Revenue has been growing slightly by 1.62% in the past year.
Measured over the past years, CXW shows a decrease in Revenue. The Revenue has been decreasing by -0.19% on average per year.
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%

3.2 Future

CXW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.86% yearly.
Based on estimates for the next years, CXW will show a quite strong growth in Revenue. The Revenue will grow by 9.81% on average per year.
EPS Next Y89.58%
EPS Next 2Y57.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.9%
Revenue Next 2Y9.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXW Yearly Revenue VS EstimatesCXW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CXW Yearly EPS VS EstimatesCXW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.94, CXW is valued on the expensive side.
CXW's Price/Earnings ratio is a bit cheaper when compared to the industry. CXW is cheaper than 67.86% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.02, CXW is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 11.84, the valuation of CXW can be described as reasonable.
CXW's Price/Forward Earnings ratio is rather cheap when compared to the industry. CXW is cheaper than 80.95% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CXW to the average of the S&P500 Index (22.57), we can say CXW is valued slightly cheaper.
Industry RankSector Rank
PE 18.94
Fwd PE 11.84
CXW Price Earnings VS Forward Price EarningsCXW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CXW's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CXW is cheaper than 73.81% of the companies in the same industry.
84.52% of the companies in the same industry are more expensive than CXW, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.28
EV/EBITDA 8.45
CXW Per share dataCXW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CXW's earnings are expected to grow with 57.86% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y57.86%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXW!.
Industry RankSector Rank
Dividend Yield N/A

CORECIVIC INC

NYSE:CXW (10/10/2025, 9:19:37 PM)

After market: 17.509 -0.48 (-2.67%)

17.99

-0.32 (-1.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05
Inst Owners90.41%
Inst Owner Change-0.02%
Ins Owners1.26%
Ins Owner Change-5.21%
Market Cap1.93B
Analysts80
Price Target30.09 (67.26%)
Short Float %2.53%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-76.74%
DP0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.38%
Min EPS beat(2)78.22%
Max EPS beat(2)84.54%
EPS beat(4)4
Avg EPS beat(4)86.21%
Min EPS beat(4)68.32%
Max EPS beat(4)113.77%
EPS beat(8)6
Avg EPS beat(8)43.4%
EPS beat(12)9
Avg EPS beat(12)30.73%
EPS beat(16)10
Avg EPS beat(16)21.5%
Revenue beat(2)2
Avg Revenue beat(2)3.98%
Min Revenue beat(2)1.11%
Max Revenue beat(2)6.86%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.11%
Max Revenue beat(4)6.86%
Revenue beat(8)7
Avg Revenue beat(8)2.28%
Revenue beat(12)7
Avg Revenue beat(12)0.98%
Revenue beat(16)7
Avg Revenue beat(16)0.19%
PT rev (1m)-4.58%
PT rev (3m)-6.35%
EPS NQ rev (1m)-2.86%
EPS NQ rev (3m)15.74%
EPS NY rev (1m)-1.29%
EPS NY rev (3m)23.34%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)4.11%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)3.63%
Valuation
Industry RankSector Rank
PE 18.94
Fwd PE 11.84
P/S 0.96
P/FCF 11.28
P/OCF 7.08
P/B 1.3
P/tB 1.31
EV/EBITDA 8.45
EPS(TTM)0.95
EY5.28%
EPS(NY)1.52
Fwd EY8.45%
FCF(TTM)1.6
FCFY8.87%
OCF(TTM)2.54
OCFY14.12%
SpS18.66
BVpS13.8
TBVpS13.76
PEG (NY)0.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROCE 7.5%
ROIC 5.45%
ROICexc 5.72%
ROICexgc 5.73%
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
FCFM 8.55%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
ROICexc(3y)4.95%
ROICexc(5y)5.26%
ROICexgc(3y)4.97%
ROICexgc(5y)5.28%
ROCE(3y)6.5%
ROCE(5y)6.83%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-5.99%
ROICexc growth 5Y-2.92%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Debt/EBITDA 3.02
Cap/Depr 80.43%
Cap/Sales 5.06%
Interest Coverage 2.77
Cash Conversion 81.6%
Profit Quality 164.18%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 1.59
F-Score8
WACC8.17%
ROIC/WACC0.67
Cap/Depr(3y)58.14%
Cap/Depr(5y)58%
Cap/Sales(3y)3.91%
Cap/Sales(5y)4.1%
Profit Quality(3y)195.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
EPS Next Y89.58%
EPS Next 2Y57.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%
Revenue Next Year8.9%
Revenue Next 2Y9.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.68%
EBIT growth 3Y-9.64%
EBIT growth 5Y-8.05%
EBIT Next Year107.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.59%
FCF growth 3Y2.78%
FCF growth 5Y4.21%
OCF growth 1Y46.88%
OCF growth 3Y0.74%
OCF growth 5Y-5.35%